Combatting maternal and neonatal sepsis will save lives and directly contribute to the achievement of SDG 3, which promotes good health and well-being. But the true burden of maternal and neonatal sepsis is presently unknown, owing to a lack of data.

GLOSS, the Global Maternal Sepsis Study, helped quantify the true burden and assess the current management of maternal and neonatal sepsis. The Study looked at how women with infection during pregnancy, childbirth or postpartum, or post-abortion are identified and treated in participating hospitals.

Over the course of one week between 28 November and 04 December 2017, the study prompted a massive coordinated data collection effort in over 700 healthcare facilities in 52 countries across the world. By clicking on the participating countries below, you will see the names of all the people involved with the study at the country level. The new and potential identification criteria were also tested and validated in this large global study.

Please follow this link for the published protocol of the study and this link for the published results on frequency and management of maternal infections.

To learn more about the study, please contact us.

Disclaimer: The boundaries and names shown and the designations used on this map do not imply official endorsement or acceptance by the World Health Organization or the Global Maternal Sepsis Study researchers.

Global Maternal Sepsis Study publications

The project has been funded by: